Fluidigm Corp at UBS Global Healthcare Conference Transcript
Great. Well, welcome. Welcome to day 2 kind of late in the morning of the UBS Global Healthcare Conference 2019. Pleased you're all here. I'm Dan Brennan. I cover the life science tool diagnostics pharma services. I'm pleased to be joined on stage by Chris Linthwaite. I hope I pronounced it right, Chris. I know we've done many calls together already during my initiation process. Chris, CEO of Fluidigm. And in the audience, we have Agnes Lee, who's IR.
So listen, I have a series of questions prepared. Would love any audience participation here who's willing to step up. So I'll look up during the presentation.
Before we get started, just you could go to UBS website at www.ubs.com, where you could see the analyst disclaimer information.
So I thought I kick off with just a high-level question, Chris, if you don't mind, and I know you've been with the company now a couple of years and certainly has
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |